Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (DE:471A)
FRANKFURT:471A
aTyr Pharma (471A) Stock Price & Analysis
2 Followers
471A Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.99 - €2.38
Previous Close€1.53
Volume300.00
Average Volume (3M)1.25K
Market Cap
€103.36M
Enterprise Value€21.32M
Total Cash (Recent Filing)$102.13M
Total Debt (Recent Filing)$15.22M
Price to Earnings (P/E)N/A
Beta0.61
Next Earnings
May 08, 2024EPS Estimate
-€0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding67,750,024
10 Day Avg. Volume20
30 Day Avg. Volume1,251
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.09
Price to Sales (P/S)9.65
Price to Cash Flow (P/CF)-2.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.99
Enterprise Value/Gross Profit2.05
Enterprise Value/Ebitda-0.68
Forecast
1Y Price Target
€19.54Price Target Upside1177.18% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
aTyr Pharma News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.09% Other Institutional Investors
99.91% Public Companies and
Individual Investors
471A FAQ
What was aTyr Pharma’s price range in the past 12 months?
aTyr Pharma lowest stock price was €0.98 and its highest was €2.38 in the past 12 months.
What is aTyr Pharma’s market cap?
Currently, no data Available
When is aTyr Pharma’s upcoming earnings report date?
aTyr Pharma’s upcoming earnings report date is May 08, 2024 which is in 18 days.
How were aTyr Pharma’s earnings last quarter?
aTyr Pharma released its earnings results on Mar 14, 2024. The company reported -€0.235 earnings per share for the quarter, missing the consensus estimate of -€0.224 by -€0.011.
Is aTyr Pharma overvalued?
According to Wall Street analysts aTyr Pharma’s price is currently Undervalued.
Does aTyr Pharma pay dividends?
aTyr Pharma does not currently pay dividends.
What is aTyr Pharma’s EPS estimate?
aTyr Pharma’s EPS estimate is -€0.24.
How many shares outstanding does aTyr Pharma have?
Currently, no data Available
What happened to aTyr Pharma’s price movement after its last earnings report?
aTyr Pharma reported an EPS of -€0.235 in its last earnings report, missing expectations of -€0.224. Following the earnings report the stock price went up 17.647%.
Which hedge fund is a major shareholder of aTyr Pharma?
Among the largest hedge funds holding aTyr Pharma’s share is Baker Bros Advisors LP. It holds aTyr Pharma’s shares valued at N/A.
---
aTyr Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€19.54 (1177.18% Upside)
€19.54 (1177.18% Upside)
Blogger Sentiment
Bullish
DE:471A Sentiment 100%
Sector Average 69%
Sector Average 69%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.18%
12-Months-Change
Fundamentals
Return on Equity
-62.16%
Trailing 12-Months
Asset Growth
27.44%
Trailing 12-Months
Company Description
aTyr Pharma
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
---
471A Earnings Call
Q4 2024
0:00 / 0:00
---
471A Stock 12 Months Forecast
Average Price Target
€19.54
▲(1177.18% Upside)
Technical Analysis
aTyr Pharma
―
Adverum Biotechnologies
―
Alnylam Pharma
―
Crispr Therapeutics AG
―
NovoCure
―
Best Analysts Covering 471A
1 Year
1 Year Success Rate
2/10 ratings generated profit
1 Year Average Return
-15.44%
reiterated a buy rating 2 months ago
Copying Sean Kim PhD's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -15.44% per trade.
---